Related Experiment Video

Updated: Jun 25, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Prolongation in QT interval is not predictive of Ca2+-dependent arrhythmias: implications for drug safety

Jean-Luc Pasquié1, Sylvain Richard

  • 1INSERM U637, Université Montpellier1 and 2, CHU Montpellier, Département de Cardiologie, F34295 Montpellier, France.

Expert Opinion on Drug Safety
|February 25, 2009
PubMed
Abstract

Insights

Drug-induced arrhythmias can occur without QT interval changes. Calcium (Ca2+)-dependent mechanisms, not just repolarization, are critical for cardiac safety assessments and preventing sudden cardiac death.

Area of Science:

  • Cardiology
  • Pharmacology
  • Molecular Biology

Background:

  • Voltage-gated ion channels are primary targets for assessing drug-induced delayed repolarization in cardiac safety.
  • Cardiac safety assessments commonly evaluate drug effects on repolarization.

Purpose of the Study:

  • To review mechanisms of drug-induced ventricular arrhythmias linked to sudden cardiac death.
  • To focus on calcium (Ca2+)-dependent mechanisms and their implications for drug safety.

Main Methods:

  • Review of existing literature on drug-induced arrhythmias.
  • Analysis of electrophysiological mechanisms, including action potential repolarization and calcium handling.
  • Examination of QT interval measurements and their limitations.

Main Results:

  • Early afterdepolarizations are linked to prolonged action potential repolarization.
  • Delayed afterdepolarizations can be triggered by intracellular Ca2+ overload or abnormal ryanodine receptor activity.
  • Drugs altering Ca2+ handling may be pro-arrhythmic, even without QT interval prolongation.

Conclusions:

  • Calcium (Ca2+)-dependent arrhythmias represent a significant concern in drug safety evaluations.
  • Investigating Ca2+-dependent mechanisms is crucial for comprehensive cardiac safety assessments.

More Related Videos

Electrocardiogram Recordings in Anesthetized Mice using Lead II04:16

Electrocardiogram Recordings in Anesthetized Mice using Lead II

Published on: June 20, 2020

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...